Which drug is a nonselective antagonist at both alpha-1 and beta receptors?

Prepare for the NBME Form 16 with our comprehensive quiz. Tackle multiple choice questions with insights and explanations. Enhance your confidence and accuracy for the exam!

Multiple Choice

Which drug is a nonselective antagonist at both alpha-1 and beta receptors?

Explanation:
Blocking both alpha-1 and beta receptors produces two simultaneous effects: alpha-1 blockade lowers peripheral vascular resistance (vasodilation), while beta blockade reduces heart rate, contractility, and renin release. Labetalol has this dual action, acting as a nonselective beta blocker with additional alpha-1 blocking activity, so it combines decreases in vascular resistance with reduced cardiac output. That makes it the best choice for a drug that antagonizes both receptor types. Propranolol blocks beta receptors without alpha-1 blockade, so it lowers heart rate and contractility but doesn’t directly cause alpha-mediated vasodilation. Prazosin blocks only alpha-1 receptors, lacking beta-blocking effects. Atenolol blocks only beta-1 receptors, with no alpha-1 blockade.

Blocking both alpha-1 and beta receptors produces two simultaneous effects: alpha-1 blockade lowers peripheral vascular resistance (vasodilation), while beta blockade reduces heart rate, contractility, and renin release. Labetalol has this dual action, acting as a nonselective beta blocker with additional alpha-1 blocking activity, so it combines decreases in vascular resistance with reduced cardiac output. That makes it the best choice for a drug that antagonizes both receptor types. Propranolol blocks beta receptors without alpha-1 blockade, so it lowers heart rate and contractility but doesn’t directly cause alpha-mediated vasodilation. Prazosin blocks only alpha-1 receptors, lacking beta-blocking effects. Atenolol blocks only beta-1 receptors, with no alpha-1 blockade.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy